A 67-Year-Old-Man with Metastatic Prostate Cancer - Episode 3

Factors for Consideration When Selecting Treatments for Patients with mCRPC

Stephen J. Freedland, MD, explains the treatment regimen he would have chosen for the patient with mCRPC in the presented case and outlines which factors, including clinical data, inform his treatment decision-making.